European stock markets showed a mixed performance on Tuesday, as investors closely monitored developments regarding Iranian peace proposals and responded to various earnings reports from regional companies. As of 12:10 p.m. in London, the pan-European Stoxx 600 index remained flat, with various sectors exhibiting varied movements.
Energy stocks emerged as the leading sector, gaining 1.6% following a surge in Brent crude prices, which reached $111 per barrel—the highest in three weeks. Meanwhile, shares in the banking sector rose by 1%, although healthcare stocks faced a downturn, falling by 1.2%.
Among the earnings reports, Swiss pharmaceutical giant Novartis saw its shares decline by 1.9% after reporting first-quarter earnings that fell short of expectations. The company disclosed a group operating income of $4.9 billion, down 12% year-on-year, compared to the anticipated $5.3 billion.
In contrast, BP, a major player in the UK energy sector, reported first-quarter earnings that more than doubled expectations, propelling its London-listed shares up by 3.1%. Barclays, however, experienced a modest decline of 0.2% after revealing a £200 million ($270 million) credit-related loss linked to exposure to a struggling property lender. Despite this setback, Barclays recorded a pre-tax profit of £2.81 billion for the quarter, a 3% increase from £2.72 billion the previous year. The bank also announced a £500 million share buyback, adding to an ongoing £1 billion program.
Airbus updated investors on its quarterly performance, with shares trading 0.4% higher by mid-day.
Investor sentiment was also influenced by news from Washington, as discussions surfaced regarding a proposal from Iranian officials to reopen the Strait of Hormuz if the U.S. agrees to lift its blockade and bring an end to ongoing hostilities. White House press secretary Karoline Leavitt indicated that U.S. President Donald Trump and his national security team were considering this offer, although Trump has previously insisted that the blockade would not be lifted until a comprehensive deal was reached.
In the background, global oil prices continued to rise amid uncertainties surrounding the war and its implications on supply.
In corporate legal news, Bayer faced the U.S. Supreme Court concerning its herbicide Roundup, in an effort to resolve numerous lawsuits alleging health issues linked to the product. The court appeared divided after hearing arguments regarding a Missouri court’s decision to award $1.25 million to an individual claiming his non-Hodgkin lymphoma diagnosis was a result of Roundup exposure. Bayer’s shares declined by 2.6% following the developments.
Looking ahead, global market participants are set to focus on key meetings from major central banks, including the U.S. Federal Reserve, European Central Bank, and Bank of England. The Fed’s policy announcement on Wednesday is particularly noteworthy, as it could mark Jerome Powell’s last meeting as the chair before Kevin Warsh is expected to assume the role next month. The Department of Justice recently terminated its criminal investigation into Powell, which may pave the way for Warsh’s confirmation.
Both the ECB and BOE are set to release their monetary policy decisions on Thursday, with expectations that they will maintain their current benchmark interest rates, while potentially signaling possible hikes later in the year amid persistent inflation concerns.
